Researchers identified patient- and tumor-level melanoma features in black individuals.
TerSera’s ZOLADEX LA receives Health Canada approval
The new dosing option of ZOLADEX is aimed at pre and perimenopausal women with an increased recurrence or advanced breast cancer risk. Credit: Gorodenkoff /